Prognostic factors after multimodality treatment for pleural mesothelioma

Clicks: 4
ID: 338171
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #137 of 147 articles by views in Interdisciplinary CardioVascular and Thoracic Surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 147 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
OBJECTIVES: To investigate prognostic factors associated with overall survival (OS) in patients with pleural mesothelioma (PM) undergoing curative-intent surgery as part of multimodality treatment (MMT). METHODS: This retrospective two-centre cohort included 255 patients treated between 2006 and 2019. OS was measured from the date of histological diagnosis and analyzed using Cox proportional hazards regression as the primary analysis. A secondary logistic regression analysis evaluated 5-year survival among patients with ascertainable 5-year vital status. A sensitivity Cox analysis used the date of surgery as the time origin. RESULTS: Among 255 patients, 77 (30.2%) survived ≥5 years after diagnosis. All 255 patients and 192 deaths were included in the primary Cox analysis. Age ≥70 years (HR 1.49, 95% CI 1.04-2.14; P=.029), non-epithelioid histology (HR 2.22, 95% CI 1.33-3.72; P=.002), preoperative T2-4 disease according to the 9th edition TNM classification (HR 2.47, 95% CI 1.78-3.43; P<.001), severe postoperative complications (HR 2.62, 95% CI 1.85-3.70; P<.001), and blood loss >1465 mL (HR 1.39, 95% CI 1.03-1.87; P=.030) were independently associated with poorer OS. Fifteen patients alive at last contact but censored before 5 years were excluded from the secondary 5-year analysis, leaving 240 patients (77 surviving ≥5 years and 163 dying before 5 years). Results were materially unchanged when OS was measured from surgery. CONCLUSIONS: Advanced age, non-epithelioid histology, higher preoperative T category according to the 9th edition TNM classification, severe postoperative complications, and greater intraoperative blood loss were independently associated with poorer OS in this highly selected surgically treated cohort.
Reference Key
openalex_W7225096776 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Masaki Hashimoto, Shota Nakamura, Akifumi Nakamura, Toru Nakamichi, Ayumi Kuroda, Kyoshiro Takegahara, Taketo Kato, Koichi Fukumoto, Seiji Matsumoto, Nobuyuki Kondo, Toyofumi Fengshi Chen-Yoshikawa, Seiki Hasegawa, Soichiro Funaki
Are you one of these authors? Claim your profile
Journal Interdisciplinary CardioVascular and Thoracic Surgery
Year 2026
DOI
10.1093/icvts/ivag296
URL
https://doi.org/10.1093/icvts/ivag296
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.